Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial

Yoshiaki Iwasaki(Katsushika Medical Center), Masanori Terashima(Shizuoka Cancer Center), Junki Mizusawa, Hiroshi Katayama, Kenichi Nakamura, Hitoshi Katai(Tokyo National Hospital), Takaki Yoshikawa(Kanagawa Prefectural Hospital Organization), Seiji Ito(Aichi Cancer Center), Masahide Kaji(Toyama Prefectural Central Hospital), Yutaka Kimura(Sakai Municipal Hospital), Motohiro Hirao(Osaka National Hospital), Makoto Yamada(Gifu Municipal Hospital), Akira Kurita(Shikoku Cancer Center), Masakazu Takagi(Shizuoka General Hospital), Sang‐Woong Lee(Osaka Medical and Pharmaceutical University), Akinori Takagane(Hakodate National Hospital), Hiroshi Yabusaki(Niigata Cancer Center Hospital), Jun Hihara(Hiroshima City Asa Citizens Hospital), Narikazu Boku(National Cancer Center Hospital East), Takeshi Sano(Japanese Foundation For Cancer Research), Mitsuru Sasako(Yodogawa Christian Hospital)
Gastric Cancer
November 16, 2020
Cited by 169Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis